Sabine Hazan
Gastroenterology · Ventura, CANPI 1669418232
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 20 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by QOL Medical, LLC at 36.9% of the total. Reporting peaked in 2019 at $541 and has fallen 89.0% since, to $60 in 2024. That places this record below the midpoint for gastroenterology clinicians in CA, where the typical reported total is $1,790.
Across 20 payments — averaging $40.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- QOL Medical, LLC$296
- Intercept Pharmaceuticals, Inc.$144
- Gilead$125
- Merck$91
- Sun Pharmaceutical Industries Inc.$49
- AbbVie$48
- plus $50 from 2 others
Across 51 payments — averaging $3478.56 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bausch Health US, LLC$37K
- Merck$31K
- Roche Products Limited$29K
- Amgen$29K
- Sanofi Pasteur Inc.$24K
- Takeda Pharmaceuticals U.S.A., Inc.$15K
- plus $12K from 6 others
What the payments were for
- Food & beverage$803100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| QOL Medical, LLC | 4 | $296 |
| Intercept Pharmaceuticals, Inc. | 2 | $144 |
| Gilead | 1 | $125 |
| Merck | 6 | $91 |
| Sun Pharmaceutical Industries Inc. | 1 | $49 |
| AbbVie | 3 | $48 |
| Shionogi Inc | 2 | $35 |
| Concordia Pharmaceuticals Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Sucraid$208
How this compares
$803 in reported general payments places this provider in the 35th percentile of 1,885 gastroenterology providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine | 13 | $98 |
| Dicyclomine Hcl | 17 | $82 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Ventura
- Bennett RothLos Angeles$2.8M
- Douglas NguyenMission Viejo$2M
- Sammy SaabLos Angeles$1.9M
- Kenneth ChangNewport Beach$1.3M
- Joo HwangStanford$1M
- Drew SchembreWalnut Creek$659K
- Quan Nhula Jolla$641K
- Sadeea AbbasiLos Angeles$556K
- Ali RezaieWest Hollywood$519K
- Kenneth BinmoellerSan Francisco$507K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.